Research and Markets (http://www.researchandmarkets.com/research/xg3msr/global_bare_metal)
has announced the addition of the "Global
Bare Metal Stents Market 2011-2015" report to their offering.
TechNavio's analysts forecast the Global Bare Metal Stents market to
reach US$1.86 billion by 2015. One of the key factors contributing to
this market growth is the high prevalence of cardiovascular diseases.
The Global Bare Metal Stents market has also been witnessing the trend
of increasing demand for minimally invasive procedures. However, the
presence of alternative coronary stents could pose a challenge to the
growth of this market.
This report has been prepared based on an in-depth analysis of the
market with inputs from industry experts. The report covers the
Americas, and the EMEA and APAC regions; it also covers the Global Bare
Metal Stents market landscape and its growth prospects in the coming
years. The report also includes a discussion of the key vendors
operating in this market.
Key vendors dominating this market space include:
Abbott Laboratories, Medtronic Inc., Cordis Corp., and Boston Scientific
Corp. Other vendors mentioned in the report: Microport Scientific Corp.,
Cook Medical, Biosensors International Ltd., B. Braun Melsungen AG.
Key questions answered in this report:
- What will the market size be in 2015 and at what rate will it grow?
- What key trends is this market subject to?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the opportunities and threats faced by each of these key
vendors?
- What are the strengths and weaknesses of each of these key vendors?
- You can request one free hour of analyst time when you purchase this
report. Details provided within the report.
Executive Summary
Commenting on the report, an analyst from TechNavio's Healthcare team
said; The development of new alloys for the manufacture of coronary
stents is expected to lead to an increase in the adoption of Bare Metal
Stents (BMSs) in the treatment of coronary heart disease (CHD). The
usage of new alloys such as cobalt-chromium (CoCr) and platinum-chromium
(PtCr) has led to the design and manufacture of advanced stents.
Traditionally, stainless steel was used in the production of BMSs.
Though flexibility and deliverability were achieved with the use of
stainless steel, there was a loss of radiopacity and compression
strength. These drawbacks were overcome through the use of CoCr stents,
which enabled manufacturers to design stents with even thinner struts
than before. This technological advancement will help drive the growth
of the Global BMS market.
According to the report, globally, cardiovascular diseases (CVDs) such
as CHD and strokes are on the rise. The increase in the incidence of CVD
is due to a variety of factors, such as obesity, diabetes, excessive
smoking and alcohol consumption, and unhealthy lifestyles. Further, the
rapidly increasing aging population is increasing the number of people
prone to CVD. All these factors drive the demand in the Global BMS
market.
Key Topics Covered:
01. Executive Summary
02. Introduction
03. Market Coverage
04. Market Landscape
05. Geographical Segmentation
06. Key Leading Countries
07. Rate of Incidence and Prevalence
08. Vendor Landscape
09. Buying Criteria
10. Market Growth Drivers
11. Drivers and their Impact
12. Market Challenges
13. Impact of Drivers and Challenges
14. Market Trends
15. Key Vendor Analysis
15.1 Abbott Laboratories
15.2 Medtronic Inc.
15.3 Cordis Corp.
15.4 Boston Scientific Corp.
16. Other Reports in this Series
For more information visit http://www.researchandmarkets.com/research/xg3msr/global_bare_metal
